SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-044015
Filing Date
2024-04-12
Accepted
2024-04-12 16:03:04
Documents
7
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A def_14a-2024_proxy.htm DEF 14A 758806
2 GRAPHIC img226992248_0.jpg GRAPHIC 9568
3 GRAPHIC img226992248_1.jpg GRAPHIC 647786
4 GRAPHIC img226992248_2.jpg GRAPHIC 647786
5 GRAPHIC img226992248_3.jpg GRAPHIC 9568
6 GRAPHIC img226992248_4.jpg GRAPHIC 371425
7 GRAPHIC img226992248_5.jpg GRAPHIC 183609
  Complete submission text file 0000950170-24-044015.txt   3323969
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39094 | Film No.: 24841396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)